Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$9.91B |
| 2 |
SPCX
SpaceX
SPCX
|
+$871M |
| 3 |
Eli Lilly
LLY
|
+$719M |
| 4 |
Amazon
AMZN
|
+$698M |
| 5 |
Netflix
NFLX
|
+$627M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$3B |
| 2 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$1.54B |
| 3 |
TSMC
TSM
|
+$1.42B |
| 4 |
NVIDIA
NVDA
|
+$1.41B |
| 5 |
SNDK
Sandisk
SNDK
|
+$771M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 82.67% |
| 2 | Technology | 3.92% |
| 3 | Healthcare | 2.55% |
| 4 | Industrials | 2.24% |
| 5 | Financials | 2.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5351
CALL
VSE Corp
VSEC
$5.13B
| $3.45M | ﹤0.01% |
15,100
+8,100
| +116% | +$1.56M |
|
5352
WisdomTree Japan Hedged Equity Fund
DXJ
$7.07B
| $3.45M | ﹤0.01% |
19,881
+10,195
| +105% | +$1.71M |
|
5353
Virtus Investment Partners
VRTS
$861M
| $3.45M | ﹤0.01% |
24,024
-17,934
| -43% | -$2.53M |
|
5354
CALL
Encompass Health
EHC
$12.2B
| $3.45M | ﹤0.01% |
34,100
+30,900
| +966% | +$3.2M |
|
5355
PUT
Vornado Realty Trust
VNO
$6.43B
| $3.45M | ﹤0.01% |
87,700
+31,100
| +55% | +$1.01M |
|
5356
WisdomTree True Emerging Markets Fund
XC
$78.5M
| $3.45M | ﹤0.01% |
108,701
+3,330
| +3% | +$107K |
|
5357
CALL
Ocular Therapeutix
OCUL
$2.18B
| $3.44M | ﹤0.01% |
350,400
-48,400
| -12% | -$439K |
|
5358
CALL
Main Street Capital
MAIN
$5.23B
| $3.44M | ﹤0.01% |
66,300
+34,300
| +107% | +$1.81M |
|
5359
CALL
Bank OZK
OZK
$5.21B
| $3.44M | ﹤0.01% |
66,000
-8,500
| -11% | -$414K |
|
|
RAPP
5360
Rapport Therapeutics
RAPP
$1.99B
| $3.44M | ﹤0.01% |
+82,442
| New | +$3.03M |
|
5361
CALL
Energizer
ENR
$1.42B
| $3.43M | ﹤0.01% |
160,200
+39,200
| +32% | +$747K |
|
5362
PUT
Indivior Pharmaceuticals
INDV
$4.06B
| $3.43M | ﹤0.01% |
83,700
+26,300
| +46% | +$954K |
|
5363
CALL
Sharplink Inc
SBET
$1.72B
| $3.43M | ﹤0.01% |
714,600
-715,200
| -50% | -$4.57M |
|
|
VSNT
5364
PUT
Versant Media Group
VSNT
$5.25B
| $3.43M | ﹤0.01% |
95,236
+13,188
| +16% | +$530K |
|
5365
CALL
Kymera Therapeutics
KYMR
$9.65B
| $3.43M | ﹤0.01% |
29,900
+2,700
| +10% | +$232K |
|
5366
PUT
Fidelity MSCI Information Technology Index ETF
FTEC
$20.8B
| $3.43M | ﹤0.01% |
12,000
+2,600
| +28% | +$680K |
|
5367
Monopar Therapeutics
MNPR
$681M
| $3.43M | ﹤0.01% |
37,004
-21,432
| -37% | -$1.33M |
|
5368
Algoma Steel
ASTL
$448M
| $3.43M | ﹤0.01% |
845,935
+578,192
| +216% | +$2.78M |
|
5369
PUT
Warby Parker
WRBY
$2.94B
| $3.43M | ﹤0.01% |
112,900
-125,000
| -53% | -$3.09M |
|
5370
PUT
VanEck High Yield Muni ETF
HYD
$4.08B
| $3.42M | ﹤0.01% |
66,400
+17,300
| +35% | +$884K |
|
5371
CF Bankshares
CFBK
$225M
| $3.41M | ﹤0.01% |
104,173
+62,572
| +150% | +$1.82M |
|
5372
PUT
ODDITY Tech
ODD
$837M
| $3.41M | ﹤0.01% |
225,600
+78,700
| +54% | +$1.05M |
|
5373
PUT
NextDecade
NEXT
$1.87B
| $3.41M | ﹤0.01% |
452,500
+152,500
| +51% | +$1.21M |
|
5374
CALL
Everspin Technologies
MRAM
$345M
| $3.41M | ﹤0.01% |
141,100
+79,500
| +129% | +$1.78M |
|
5375
PUT
Brookfield
BN
$82.4B
| $3.41M | ﹤0.01% |
80,000
-48,600
| -38% | -$2.17M |
|
Similar funds
Citadel Advisors's Q2 2026 Portfolio in Review
As of Q2 2026, Citadel Advisors held 15,445 positions worth $875B, up 41% from $618B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Citadel Advisors's Q2 2026 filing shows 2,573 new, 6,088 increased, 4,803 reduced and 1,873 closed positions. Its largest new stake was SpaceX: 5,129,884 shares worth $876M. The largest sale was Micron Technology, an estimated $3B.
By sector, the portfolio is most concentrated in Miscellaneous at 83% of assets, up from 79% a quarter earlier, followed by Technology and Healthcare.
- Citadel Advisors's largest Q2 2026 buy was SpaceX: 5,129,884 shares worth $876M.
- Citadel Advisors added most to iShares Core S&P 500 ETF in Q2 2026, an estimated $9.91B increase.
- Citadel Advisors's biggest Q2 2026 reduction was Micron Technology, cutting an estimated $3B.
- Citadel Advisors fully exited iShares 7-10 Year Treasury Bond ETF in Q2 2026, selling an estimated $325M.
- Citadel Advisors's ten largest holdings make up 23% of its $875B portfolio in Q2 2026.
- Citadel Advisors opened 2,573 new positions and closed 1,873 in Q2 2026.
- Citadel Advisors's portfolio value rose 41% quarter-over-quarter to $875B.
Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.